Carolyn Anderson, PhD
|Medical/Graduate School||Florida State University|
|Clinical/Post-doctoral Fellowship||Washington University|
|Clinical Interest||Translating novel PET agents for imaging of disease into humans|
|Research Interest||Development of novel molecular imaging agents that target immune cells and other diseases|
|Selected Publications||1.Lux J, White AG, Chan M, Anderson CJ*, Almutairi A*. Nanogels from Metal-Chelating Crosslinkers as Versatile Platforms Applied to Copper-64 PET Imaging of Tumors and Metastases. Theranostics, 2015; 3: 277-288. (*co-corresponding authors)
2.Ocak M, Gillman AG, Bresee J, Zhang L, Vlad AM, Mueller C, Schibli R, Edwards WB, Anderson CJ, Gach HM. Folate Receptor-Targeted Multimodality Imaging of Ovarian Cancer in a Novel Syngeneic Mouse Model. Molecular Pharmaceutics, 2015; 12:542-53.
3.Cai Z, Li BTY, Wong EH, Weisman GR, Anderson CJ. Cu(I)-assisted Click Chemistry Strategy for Conjugation of Non-protected Cross-bridged Macrocyclic Chelators to Tumour-targeting Peptides. Dalton Transactions, 2015, 44, 3945 3948.
4.Zhang S, Shao P, Ling X, Yang L, Hou W, Thorn SH, Beaino W, Anderson CJ, Ding Y, Bai M. In vivo Inflammation Imaging using a CB2R-targeted Near Infrared Fluorescent Probe. American Journal of Nuclear Medicine and Medical Imaging, 2015; 5:246-258.
5Beaino W#, Nedrow J#, Anderson CJ. Evaluation of 68Ga- and 177Lu-DOTA-PEG4-LLP2A for VLA-4 targeted PET imaging and treatment of metastatic melanoma. Molecular Pharmaceutics, 2015; 12:1929-1938. (#These two authors contributed equally)
6. Patel SK#, Beaino W#, Anderson CJ*, Janjic JM*. Theranostic nanoemulsions for macrophage COX-2 inhibition in a murine inflammation model. Clinical Immunology, 2015; 160:59-70. (#These two authors contributed equally; *co-corresponding authors).
7.Song J, Cai Z, White AG, Jin T, Wang X, Kadayakkara D, Anderson CJ, Ambrose Z, Young W-B. Visualization and quantification of simian immunodeficiency virus (SIV)-infected cells using non-invasive molecular imaging. Journal of General Virology, 2015; 96:3131-3142.
8.Sun L, Gai Y, Anderson CJ, Zeng D. Highly efficient and versatile fluorous-tagged Cu(I) catalyzed azide-alkyne cycloaddition ligand for preparing bioconjugates. ChemComm, 2015; 51:17072-17075
9.Cai Z, Mason NS, Anderson CJ, Edwards WB. Synthesis and preliminary evaluation of an 18F-labeled oleic acid analog for PET imaging of fatty acid uptake and metabolism. Nuclear Medicine and Biology; 2016; 43:108-115.
10.Nedrow JR, Day KE, Latoche JD, Modi J, Ganguly T, Zeng D, Kurland BF, Berkman CE, Anderson CJ. Targeting PSMA with a 64Cu-labeled phosphoramidate inhibitor for PET/CT imaging of variant PSMA-expressing xenografts in mouse models of prostate cancer. Molecular Imaging and Biology, published on-line November 9, 2015; doi:10.1007/s11307-015-0908-7.
11.Soodgupta D, Zhou H, Beaino W, Lu L, Snee M, Rettig M, Skeath J, DiPersio JF, Akers WJ, Laforest R, Weilbaecher K, Anderson CJ, Tomasson MH, Shokeen M. Ex Vivo and In vivo evaluation of over-expressed VLA-4 using LLP2A imaging agents. Journal of Nuclear Medicine, published on January 7, 2016 as doi:10.2967/jnumed.115.164624
12.Shakir M, Tang D, Zeh HJ, Tang SW, Anderson CJ, Bahary N, Lotze MT. Finding Flow: The Chemokine Receptors CXCR4/CXCR7 and Their Primary Heterodimeric Ligands CXCL12 and CXCL12/HMGB1 in Pancreatic Cancer Growth and Development. Pancreas, 2015; 44:528-534.
13.Nedrow JR, Anderson CJ. Emerging Radiometals for PET Imaging. Encyclopedia of Inorganic and Bioinorganic Chemistry. In press.
|Distinguished Investigator of the Academy of Radiology Research (2014)
Michael J. Welch Lecture in Oncological Imaging (2015)
|PubMed Publications||See a listing of publications on PubMed, a service of the National Library of medicine.|